Table 1.
Demographic Features and Underlying Conditions | N (%) |
---|---|
Median age (neonates-84 years) | 40 years |
Adults (≥19 years) | 72 (64) |
Pediatric population | 40 (36) |
Neonates (≤1 months) | 11 (10) |
Infants (≤12 months) | 17 (15) |
Toddlers/Children (1–18 years) | 10 (9) |
Unknown age | 2 (2) |
Gender | |
Females | 37 (33) |
Males | 69 (62) |
Unknown | 6 (5) |
Underlying conditions | |
Solid tumors | 5 (4) |
Hematologic malignancy | 18 (16) |
Aplastic anemia | 1 (1) |
Solid organ transplantation | 10 (9) |
Bone marrow transplantation | 3 (3) |
Surgery | 39 (35) |
Facial/Neck | 0 (0) |
Thoracic | 4 (4) |
Abdominal | 20 (18) |
Orthopedic | 15 (13) |
Prior broad-spectrum antibiotics | 73 (65) |
Prior antifungal agents | 35 (31) |
Central venous catheter | 17 (15) |
Open fracture | 0 (0) |
Trauma/open wound | 10 (9) |
HIV | 4 (4) |
IVDU | 10 (9) |
Alcohol abuse | 5 (4) |
Hemodialysis | 6 (5) |
Neutropenia | 10 (9) |
Corticosteroids | 20 (18) |
Pharmacological immunosuppression other than steroids | 19 (17) |
Hypogammaglobulinemia | 2 (2) |
Chronic Pulmonary Disease | 4 (4) |
Abdominal abscess | 1 (1) |
GI rupture | 1 (1) |
Necrotic enterocolitis | 2 (2) |
Congenital disorder (gastroschisis, Hirschsprung's disease) | 7 (6) |
Total parenteral nutrition | 14 (13) |
Diabetes mellitus | 11 (10) |
Rheumatoid arthritis | 2 (2) |
Intensive care unit | 6 (5) |
None | 3 (3) |
Preexisting invasive candidiasis | 71 (63) |
Candidemia | 32 (29) |
Other forms of candidiasisa | 39 (35) |
Candidemia at time of diagnosis of Candida arthritis | 12 (11) |
Abbreviations: CNS, central nervous system; GI, gastrointestinal; HIV, human immunodeficiency virus;IVDU, intravenous drug use.
a Central venous catheter infection, candiduria, orbital candidiasis, and otitis, cutaneous, pulmonary, or CNS infection.